AOP	AOP name	Event	Level of Organisation	Event Action	Action
Aop:1	Uncharacterized liver damage leading to hepatocellular carcinoma	Event:294	Molecular	N/A	
Aop:1	Uncharacterized liver damage leading to hepatocellular carcinoma	Event:57	Cellular	Proliferation	increased process quality
Aop:1	Uncharacterized liver damage leading to hepatocellular carcinoma	Event:142	Tissue	Hyperplasia	increased object quality
Aop:1	Uncharacterized liver damage leading to hepatocellular carcinoma	Event:334	Individual	Promotion	increased object quality
Aop:3	Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits	Event:888	Molecular	Binding of inhibitor	decreased process quality
Aop:3	Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits	Event:887	Cellular	Inhibition	decreased process quality
Aop:3	Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits	Event:177	Cellular	N/A	damage
Aop:3	Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits	Event:889	Cellular	impaired	deviation(from_normal)
Aop:3	Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits	Event:188	Tissue	N/A	pathological
Aop:3	Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits	Event:890	Organ	Increased	increased object quality
Aop:3	Inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits	Event:896	Individual	Increased	occurrence
Aop:4	Ecdysone receptor agonism leading to mortality	Event:103	Molecular	Activation	increased process quality
Aop:4	Ecdysone receptor agonism leading to mortality	Event:988	Cellular	Decreased	deviation(from_normal)
Aop:4	Ecdysone receptor agonism leading to mortality	Event:990	Organ	Increased	increased process quality
Aop:4	Ecdysone receptor agonism leading to mortality	Event:993	Organ	Decreased	increased process quality
Aop:4	Ecdysone receptor agonism leading to mortality	Event:351	Individual	Increase	increased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:998	Molecular	Binding of antagonist	decreased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:1000	Molecular	stabilization	increased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:1000	Molecular	stabilization	increased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:858	Molecular	Decreased	decreased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:859	Molecular	Decreased	decreased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:860	Molecular	Decreased	decreased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:861	Molecular	Decreased	decreased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:862	Tissue	Not Increased	deviation(from_normal)
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:862	Tissue	Not Increased	deviation(from_normal)
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:863	Organ	Increased	increased process quality
Aop:6	Antagonist binding to PPARalpha leading to starvation-like body-weight loss	Event:864	Individual	Decreased	decreased object quality 
Aop:7	Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female	Event:408	Cellular	reduction in ovarian granulosa cells	decreased process quality
Aop:7	Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female	Event:219	Organ	Reduction	decreased object quality 
Aop:7	Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female	Event:219	Organ	Reduction	decreased concentration
Aop:7	Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female	Event:3	Cellular	Reduction	decreased process quality
Aop:7	Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female	Event:406	Individual	impaired	decreased object quality
Aop:7	Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female	Event:405	Individual	irregularities	disrupted
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:239	Molecular	Activation	increased process quality
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:295	Molecular	Induction	increased process quality
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:401	Organ	Increase	increased process quality
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:281	Tissue	Decreased	decreased object quality 
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:281	Tissue	Decreased	decreased concentration
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:280	Organ	Decreased	decreased object quality 
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:280	Organ	Decreased	decreased concentration
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:756	Tissue	Altered	deviation(from_normal)
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:757	Organ	Altered	abnormal
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:758	Tissue	Decreased	decreased process quality
Aop:8	"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals"	Event:319	Organ	Loss	increased object quality
Aop:10	Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures	Event:667	Molecular	Binding at picrotoxin site	increased process quality
Aop:10	Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures	Event:64	Cellular	Reduction	decreased process quality
Aop:10	Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures	Event:616	Tissue	Occurrence	occurrence
Aop:10	Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures	Event:669	Cellular	Reduction	decreased process quality
Aop:10	Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures	Event:682	Tissue	Generation	occurrence
Aop:10	Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures	Event:613	Individual	Occurrence	occurrence
Aop:11	Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol	Event:245	Molecular	Activation	
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:201	Molecular	Binding of antagonist	decreased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:195	Molecular	Inhibition	decreased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:52	Cellular	Decreased	decreased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:381	Molecular	Reduced	decreased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:381	Molecular	Reduced	decreased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:55	Cellular	N/A	increased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:188	Tissue	N/A	pathological
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:352	Tissue	N/A	increased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:341	Individual	Impairment	decreased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:341	Individual	Impairment	decreased process quality
Aop:12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration in aging	Event:385	Cellular	Decreased	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:201	Molecular	Binding of antagonist	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:195	Molecular	Inhibition	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:52	Cellular	Decreased	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:381	Molecular	Reduced	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:381	Molecular	Reduced	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:382	Cellular	Aberrant	abnormal
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:383	Molecular	Reduced	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:55	Cellular	N/A	increased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:385	Cellular	Decreased	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:386	Organ	Decreased	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:341	Individual	Impairment	decreased process quality
Aop:13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities	Event:341	Individual	Impairment	decreased process quality
Aop:14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility	Event:122	Molecular	Activation	increased process quality
Aop:14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility	Event:202	Molecular	Inhibition	decreased process quality
Aop:14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility	Event:152	Individual	Suppression	decreased process quality
Aop:14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility	Event:168	Individual	Decreased	decreased amount
Aop:14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility	Event:145	Cellular	Induction	increased process quality
Aop:14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility	Event:403	Individual	Suppression	increased process quality
Aop:14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility	Event:323	Individual	Increased	increased process quality
Aop:15	Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations	Event:97	Molecular	Alkylation	increased process quality
Aop:15	Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations	Event:185	Molecular	Increase	increased process quality
Aop:15	Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations	Event:336	Individual	Increase	increased process quality
Aop:15	Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations	Event:155	Cellular	N/A	insufficient
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:12	Cellular	Inhibition	decreased process quality
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:10	Cellular	Accumulation	increased amount
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:444	Organ	Increased	increased object quality
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:444	Organ	Increased	increased object quality
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:445	Organ	Increased	increased object quality
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:39	Organ	Induction	increased object quality
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:39	Organ	Induction	increased object quality
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:39	Organ	Induction	increased object quality
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:442	Individual	Decreased	decreased rate
Aop:16	Acetylcholinesterase inhibition leading to acute mortality	Event:351	Population	Increased	increased process quality
Aop:17	Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration	Event:261	Molecular	Binding	occurrence
Aop:17	Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration	Event:158	Cellular	N/A	disrupted
Aop:17	Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration	Event:130	Cellular	Depletion	decreased concentration
Aop:17	Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration	Event:210	Cellular	N/A	occurrence
Aop:17	Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration	Event:191	Cellular	N/A	increased process quality
Aop:17	Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration	Event:188	Tissue	N/A	pathological
Aop:17	Binding to SH/selen-proteins can trigger neuroinflammation leading to neurodegeneration	Event:352	Tissue	N/A	increased object quality
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:227	Molecular	Activation	increased process quality
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:266	Cellular	Decrease	decreased process quality
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:289	Cellular	Decrease	decreased process quality
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:447	Cellular	Reduction	decreased process quality
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:413	Cellular	Reduction	decreased process quality
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:446	Individual	Reduction	decreased object quality 
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:446	Individual	Reduction	decreased concentration
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:348	Individual	Malformation	malformed
Aop:18	PPARalpha activation in utero leading to impaired fertility in males	Event:406	Individual	impaired	decreased object quality
Aop:19	Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)	Event:27	Molecular	N/A	decreased process quality
Aop:19	Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)	Event:310	Cellular	Alteration	deviation(from_normal)
Aop:19	Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)	Event:240	Organ	Feminisation or incomplete development	arrested
Aop:19	Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)	Event:286	Cellular	Decreased	decreased process quality
Aop:19	Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)	Event:286	Cellular	Decreased	decreased process quality
Aop:19	Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)	Event:337	Individual	N/A	decreased object quality
Aop:21	Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality	Event:18	Molecular	Activation	increased process quality
Aop:21	Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality	Event:944	Molecular	"dimerization, AHR/ARNT"	disrupted
Aop:21	Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality	Event:944	Molecular	"dimerization, AHR/ARNT"	disrupted
Aop:21	Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality	Event:317	Organ	"Altered, Cardiovascular development/function"	deformed
Aop:21	Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality	Event:317	Organ	"Altered, Cardiovascular development/function"	deformed
Aop:21	Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality	Event:1269	Molecular	"Increase, COX-2 expression"	increased process quality
Aop:21	Activation of the aryl hydrocarbon receptor (AhR) leading to early life stage mortality	Event:350	Individual	"Increase, Mortality"	increased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:25	Molecular	Agonism	increased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:274	Cellular	Reduction	decreased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:3	Cellular	Reduction	decreased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:219	Organ	Reduction	decreased object quality 
Aop:23	Aromatase inhibition leading to reproductive dysfunction	Event:219	Organ	Reduction	decreased concentration
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:285	Tissue	Reduction	decreased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:78	Individual	Reduction	decreased amount
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:221	Organ	Reduction	decreased object quality 
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:221	Organ	Reduction	decreased concentration
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:129	Organ	Reduction	decreased object quality 
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:129	Organ	Reduction	decreased concentration
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:129	Organ	Reduction	decreased concentration
Aop:23	Androgen receptor agonism leading to reproductive dysfunction	Event:360	Population	Decrease	decreased rate
Aop:24	Androgen receptor antagonism leading to reproductive dysfunction	Event:26	Molecular	Antagonism	decreased process quality
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:36	Molecular	Inhibition	decreased process quality
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:3	Cellular	Reduction	decreased process quality
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:219	Organ	Reduction	decreased object quality 
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:219	Organ	Reduction	decreased concentration
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:285	Tissue	Reduction	decreased process quality
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:221	Organ	Reduction	decreased object quality 
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:221	Organ	Reduction	decreased concentration
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:78	Individual	Reduction	decreased amount
Aop:25	Aromatase inhibition leading to reproductive dysfunction	Event:360	Population	Decrease	decreased rate
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:51	Molecular	Inhibition	decreased process quality
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:50	Cellular	Increase	increased amount
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:178	Cellular	Disruption	disrupted
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:40	Cellular	Decreased	decreased process quality
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:257	Cellular	Increased	increased process quality
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:193	Cellular	Decreased	decreased amount
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:166	Organ	Decreased	decreased process quality
Aop:26	Calcium-mediated neuronal ROS production and energy imbalance	Event:356	Individual	Increased	increased object quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:41	Molecular	Inhibition	decreased process quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:288	Cellular	Activation of specific nuclear receptors	increased process quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:288	Cellular	Activation of specific nuclear receptors	increased process quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:288	Cellular	Activation of specific nuclear receptors	increased process quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:214	Cellular	Bile accumulation	increased amount
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:87	Cellular	Release	increased process quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:149	Cellular	Increase	increased process quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:249	Tissue	Production	increased process quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:209	Cellular	Increase	increased object quality
Aop:27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)	Event:357	Individual	Cholestasis	occurrence
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:79	Molecular	Inhibition	decreased process quality
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:79	Molecular	Inhibition	decreased process quality
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:243	Tissue	Reduction	decreased object quality 
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:243	Tissue	Reduction	decreased concentration
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:49	Tissue	Reduction	decreased process quality
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:49	Tissue	Reduction	decreased process quality
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:106	Tissue	Reduction	decreased thickness
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:119	Tissue	N/A	damage
Aop:28	Cyclooxygenase inhibition leading reproductive failure	Event:253	Individual	N/A	deviation(from_normal)
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:111	Molecular	Agonism	increased process quality
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:78	Individual	Reduction	decreased amount
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:220	Organ	Increase	increased object quality 
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:220	Organ	Increase	increased concentration
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:307	Tissue	Increase	increased process quality
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:252	Organ	Increase	increased process quality
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:360	Population	Decrease	decreased rate
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:363	Individual	Altered	deviation(from_normal)
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:339	Individual	Altered	deviation(from_normal)
Aop:29	Estrogen receptor agonism leading to reproductive dysfunction	Event:364	Individual	Impaired development of	abnormal
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:112	Molecular	Antagonism	decreased process quality
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:285	Tissue	Reduction	decreased process quality
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:221	Organ	Reduction	decreased concentration
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:221	Organ	Reduction	decreased concentration
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:309	Cellular	Reduction	decreased process quality
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:78	Individual	Reduction	decreased amount
Aop:30	Estrogen receptor antagonism leading to reproductive dysfunction	Event:360	Population	Decrease	decreased rate
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:213	Molecular	N/A	increased process quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:21	Cellular	Altered regulation	deviation(from_normal)
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:211	Molecular	Propagation	increased process quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:250	Cellular	Damaging	increased process quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:118	Cellular	Formation	increased process quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:118	Cellular	Formation	increased process quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:131	Cellular	Down Regulation	decreased process quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:246	Organ	Increase	increased object quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:246	Organ	Increase	increased object quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:161	Organ	Increase	increased object quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:161	Organ	Increase	increased object quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:173	Organ	N/A	increased object quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:173	Organ	N/A	increased object quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:173	Organ	N/A	increased object quality
Aop:31	Oxidation of iron in hemoglobin leading to hematotoxicity	Event:321	Individual	N/A	occurrence
Aop:32	"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors"	Event:77	Cellular	Production	increased process quality
Aop:32	"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors"	Event:77	Cellular	Production	increased process quality
Aop:32	"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors"	Event:164	Organ	Induction	decreased object quality
Aop:32	"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors"	Event:147	Cellular	Inhibition	decreased process quality
Aop:32	"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors"	Event:270	Individual	Induction	increased process quality
Aop:32	"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors"	Event:269	Cellular	Induction	increased process quality
Aop:32	"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors"	Event:347	Individual	Formation	increased object quality
Aop:33	Kidney toxicity induced by activation of 5HT2C	Event:9	Molecular	Activation	increased process quality
Aop:33	Kidney toxicity induced by activation of 5HT2C	Event:294	Cellular	N/A	
Aop:33	Kidney toxicity induced by activation of 5HT2C	Event:759	Individual	Increased	increased object quality
Aop:34	LXR activation leading to hepatic steatosis	Event:167	Molecular	Activation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:167	Molecular	Activation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:228	Molecular	Activation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:54	Molecular	Up Regulation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:115	Cellular	Increase	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:66	Molecular	Activation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:264	Molecular	Activation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:116	Molecular	Activation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:258	Molecular	Activation	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:89	Cellular	Synthesis	increased process quality
Aop:34	LXR activation leading to hepatic steatosis	Event:291	Cellular	Accumulation	increased concentration
Aop:34	LXR activation leading to hepatic steatosis	Event:176	Cellular	Damaging	damage
Aop:34	LXR activation leading to hepatic steatosis	Event:345	Organ	N/A	occurrence
Aop:35	Narcosis leading to respiratory failure	Event:46	Cellular	Accumulation	increased object quality
Aop:35	Narcosis leading to respiratory failure	Event:169	Cellular	Disruption	increased object quality
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:231	Molecular	Decreased	decreased process quality
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:232	Molecular	Decreased	decreased process quality
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:233	Molecular	Decreased	decreased process quality
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:327	Organ	Accumulation	increased concentration
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:140	Cellular	Decreased	decreased process quality
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:179	Molecular	Decreased	decreased process quality
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:8	Cellular	Decreased	decreased process quality
Aop:36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis	Event:346	Organ	Undefined	occurrence
Aop:38	Protein Alkylation leading to Liver Fibrosis	Event:68	Tissue	Accumulation	increased process quality
Aop:38	Protein Alkylation leading to Liver Fibrosis	Event:265	Cellular	Activation	increased process quality
Aop:38	Protein Alkylation leading to Liver Fibrosis	Event:244	Molecular	Alkylation	increased process quality
Aop:38	Protein Alkylation leading to Liver Fibrosis	Event:134	Cellular	Increased	increased process quality
Aop:38	Protein Alkylation leading to Liver Fibrosis	Event:55	Cellular	N/A	increased process quality
Aop:38	Protein Alkylation leading to Liver Fibrosis	Event:344	Organ	N/A	occurrence
Aop:38	Protein Alkylation leading to Liver Fibrosis	Event:276	Cellular	Up Regulation	increased process quality
Aop:39	Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins	Event:75	Molecular	N/A	
Aop:39	Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins	Event:151	Molecular	Activation	increased process quality
Aop:39	Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins	Event:151	Molecular	Activation	increased process quality
Aop:39	Sensitisation of the Respiratory Tract induced by Covalent Binding of Low Molecular Weight Organic Chemicals to Proteins	Event:313	Organ	Increase	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:396	Molecular	Covalent Binding	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:826	Cellular	Activation	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:826	Cellular	Activation	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:398	Cellular	Activation	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:398	Cellular	Activation	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:272	Organ	Activation/Proliferation	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:272	Organ	Activation/Proliferation	increased process quality
Aop:40	Covalent Protein binding leading to Skin Sensitisation	Event:827	Organ	sensitisation	increased process quality
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:165	Cellular	Activation	increased process quality
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:853	Cellular	Changes/Inhibition	deviation(from_normal)
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:853	Cellular	Changes/Inhibition	decreased process quality
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:139	Tissue	N/A	occurrence
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:854	Tissue	Alterations	deviation(from_normal)
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:854	Tissue	Alterations	increased process quality
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:854	Tissue	Alterations	increased process quality
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:856	Organ	Formation	increased object quality
Aop:41	Sustained AhR Activation leading to Rodent Liver Tumours	Event:856	Organ	Formation	increased object quality
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:279	Molecular	Inhibition	decreased process quality
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:277	Molecular	Decreased	decreased process quality
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:281	Tissue	Decreased	decreased concentration
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:280	Organ	Decreased	decreased concentration
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:756	Tissue	Altered	deviation(from_normal)
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:757	Organ	Altered	malformed
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:758	Tissue	Decreased	abnormal
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:402	Individual	Decreased	decreased process quality
Aop:42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:402	Individual	Decreased	decreased process quality
Aop:43	Disruption of VEGFR Signaling Leading to Developmental Defects	Event:305	Molecular	Inhibition	decreased process quality
Aop:43	Disruption of VEGFR Signaling Leading to Developmental Defects	Event:28	Cellular	Reduction	decreased process quality
Aop:43	Disruption of VEGFR Signaling Leading to Developmental Defects	Event:110	Tissue	Impairment	deviation(from_normal)
Aop:43	Disruption of VEGFR Signaling Leading to Developmental Defects	Event:298	Organ	Insufficiency	decreased process quality
Aop:43	Disruption of VEGFR Signaling Leading to Developmental Defects	Event:298	Organ	Insufficiency	abnormal
Aop:43	Disruption of VEGFR Signaling Leading to Developmental Defects	Event:1001	Individual	Increased	malformed
Aop:46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)	Event:373	Molecular	Formation	deviation(from_normal)
Aop:46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)	Event:409	Molecular	Metabolism of AFB1	increased process quality
Aop:46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)	Event:376	Cellular	Increased	increased process quality
Aop:46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)	Event:491	Organ	Clonal Expansion/Cell Proliferation	increased process quality
Aop:46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)	Event:493	Molecular	Increased	insufficient 
Aop:46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)	Event:378	Individual	Tumorigenesis	increased object quality
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:875	Molecular	Binding of agonist	increased process quality
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:388	Molecular	Overactivation	increased process quality
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:389	Cellular	Increased	increased concentration
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:177	Cellular	N/A	damage
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:55	Cellular	N/A	increased process quality
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:188	Tissue	N/A	pathological
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:352	Tissue	N/A	increased process quality
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:618	Organ	Decreased	decreased process quality
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:341	Individual	Impairment	decreased process quality
Aop:48	"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment."	Event:341	Individual	Impairment	decreased process quality
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:227	Molecular	Activation	increased process quality
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:414	Cellular	Increase	increased process quality
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:415	Cellular	Hyperplasia	increased process quality
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:416	Cellular	Increase proliferation	increased process quality
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:413	Cellular	Reduction	decreased process quality
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:446	Individual	Reduction	decreased object quality 
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:446	Individual	Reduction	decreased concentration
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:447	Cellular	Reduction	decreased process quality
Aop:51	PPARalpha activation leading to impaired fertility in adult male rodents	Event:406	Individual	impaired	decreased object quality
Aop:52	ER agonism leading to skewed sex ratios due to altered sexual differentiation in males	Event:111	Molecular	Agonism	increased process quality
Aop:52	ER agonism leading to skewed sex ratios due to altered sexual differentiation in males	Event:417	Population	skewed	deviation(from_normal)
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:111	Molecular	Agonism	increased process quality
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:418	Cellular	Increased	increased process quality
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:220	Organ	Increase	increased object quality 
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:220	Organ	Increase	increased concentration
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:419	Organ	Increased	increased concentration
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:421	Organ	Increased	damage
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:421	Organ	Increased	increased object quality
Aop:53	ER agonism leading to reduced survival due to renal failure	Event:422	Individual	Increased	increased object quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:424	Molecular	Inhibition	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:425	Cellular	Decreased	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:277	Molecular	Decreased	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:281	Tissue	Decreased	decreased object quality 
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:281	Tissue	Decreased	decreased concentration
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:280	Organ	Decreased	decreased object quality 
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:280	Organ	Decreased	decreased concentration
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:381	Molecular	Reduced	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:381	Molecular	Reduced	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:851	Cellular	Altered	deviation(from_normal)
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:851	Cellular	Altered	deviation(from_normal)
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:385	Cellular	Decreased	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:386	Organ	Decreased	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:341	Individual	Impairment	decreased process quality
Aop:54	Inhibition of Na+/I- symporter (NIS) decreases TH synthesis leading to learning and memory deficits in children	Event:341	Individual	Impairment	decreased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:18	Molecular	Activation	increased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:450	Cellular	Suppression	decreased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:451	Molecular	Inhibition	decreased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:327	Organ	Accumulation	increased concentration
Aop:57	AhR activation leading to hepatic steatosis	Event:216	Cellular	Decreased	decreased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:291	Cellular	Accumulation	increased concentration
Aop:57	AhR activation leading to hepatic steatosis	Event:54	Molecular	Up Regulation	increased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:464	Molecular	Increased	increased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:465	Cellular	Increased	increased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:466	Molecular	Up Regulation	increased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:467	Cellular	Increased	increased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:80	Molecular	Up Regulation	increased process quality
Aop:57	AhR activation leading to hepatic steatosis	Event:455	Organ	Accumulation	increased concentration
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:456	Molecular	Suppression	decreased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:468	Molecular	Inhibition	decreased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:167	Molecular	Activation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:167	Molecular	Activation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:228	Molecular	Activation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:457	Molecular	Activation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:66	Molecular	Activation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:458	Cellular	Increased	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:460	Cellular	Increased	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:454	Cellular	Increased	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:54	Molecular	Up Regulation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:462	Molecular	Up Regulation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:463	Molecular	Up Regulation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:451	Molecular	Inhibition	decreased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:327	Organ	Accumulation	increased concentration
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:470	Molecular	Up Regulation	increased process quality
Aop:58	NR1I3 (CAR) suppression leading to hepatic steatosis	Event:459	Organ	Increased	increased object quality
Aop:59	HNF4alpha suppression leading to hepatic steatosis	Event:461	Molecular	Suppression	decreased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:245	Molecular	Activation	increased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:471	Molecular	Inhibition	decreased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:179	Molecular	Decreased	decreased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:472	Molecular	Down Regulation	decreased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:474	Molecular	Down Regulation	decreased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:462	Molecular	Up Regulation	increased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:54	Molecular	Up Regulation	increased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:475	Cellular	Increased	increased concentration
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:465	Cellular	Increased	increased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:476	Organ	Accumulation	increased concentration
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:477	Cellular	Decreased	decreased process quality
Aop:60	"NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis"	Event:459	Organ	Increased	increased object quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:478	Molecular	Activation	increased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:479	Molecular	Activation	increased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:480	Molecular	Activation	increased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:227	Molecular	Activation	increased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:482	Molecular	Decreased	decreased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:451	Molecular	Inhibition	decreased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:483	Molecular	Activation	increased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:878	Molecular	Inhibition	increased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:879	Cellular	Activation	increased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:880	Tissue	Increased	increased concentration
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:881	Cellular	Increased	increased concentration
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:882	Cellular	Decreased	decreased process quality
Aop:61	NFE2L2/FXR activation leading to hepatic steatosis	Event:459	Organ	Increased	increased object quality
Aop:62	AKT2 activation leading to hepatic steatosis	Event:486	Molecular	Activation	increased process quality
Aop:62	AKT2 activation leading to hepatic steatosis	Event:484	Molecular	Activation	increased process quality
Aop:62	AKT2 activation leading to hepatic steatosis	Event:485	Molecular	Activtation	increased process quality
Aop:62	AKT2 activation leading to hepatic steatosis	Event:459	Organ	Increased	increased object quality
Aop:63	Cyclooxygenase inhibition leading to reproductive dysfunction	Event:79	Molecular	Inhibition	decreased process quality
Aop:63	Cyclooxygenase inhibition leading to reproductive dysfunction	Event:79	Molecular	Inhibition	decreased process quality
Aop:63	Cyclooxygenase inhibition leading to reproductive dysfunction	Event:488	Tissue	Decrease	decreased process quality
Aop:63	Cyclooxygenase inhibition leading to reproductive dysfunction	Event:685	Organ	Reduced	decreased concentration
Aop:63	Cyclooxygenase inhibition leading to reproductive dysfunction	Event:675	Individual	Reduced	decreased process quality
Aop:63	Cyclooxygenase inhibition leading to reproductive dysfunction	Event:686	Population	Declining	decreased rate
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:494	Molecular	Activation of specific nuclear receptors	increased process quality
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:495	Cellular	Abnormal steroidogenic gene expression	decreased process quality
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:496	Cellular	Increased Apoptosis	increased process quality
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:497	Individual	Decreased Sperm Number	decreased object quality
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:497	Individual	Decreased Sperm Number	decreased amount
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:498	Individual	Accelerated Epididymal Sperm Transit	decreased object quality
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:498	Individual	Accelerated Epididymal Sperm Transit	increased process quality
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:499	Individual	Abnormal Sperm Maturation	decreased object quality
Aop:64	Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility	Event:499	Individual	Abnormal Sperm Maturation	decreased object quality
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:424	Molecular	Inhibition	decreased process quality
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:277	Molecular	Decreased	decreased process quality
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:281	Tissue	Decreased	decreased object quality 
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:281	Tissue	Decreased	decreased concentration
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:280	Organ	Decreased	decreased concentration
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:280	Organ	Decreased	decreased concentration
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:186	Organ	Altered	deviation(from_normal)
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:192	Organ	Altered	deviation(from_normal)
Aop:65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:402	Individual	Decreased	decreased process quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:653	Cellular	Decreased testosterone by the fetal Leydig cells	increased concentration
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:653	Cellular	Decreased testosterone by the fetal Leydig cells	increased concentration
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:654	Cellular	Decreased testosterone by the fetal Leydig cells	increased process quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:655	Cellular	Decreased testosterone by the fetal Leydig cells	increased process quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:657	Organ	Decreased testosterone by the fetal Leydig cells	increased object quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:657	Organ	Decreased testosterone by the fetal Leydig cells	increased object quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:656	Cellular	Decreased number and function of adult Leydig cells	decreased process quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:656	Cellular	Decreased number and function of adult Leydig cells	increased object quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased object quality
Aop:66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased amount
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:658	Cellular	Decreased testosterone by the fetal Leydig cells	increased concentration
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:659	Cellular	Decreased testosterone by the fetal Leydig cells	
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:655	Cellular	Decreased testosterone by the fetal Leydig cells	increased process quality
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:660	Organ	decreased testosterone by fetal Leydig cells	increased object quality
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:660	Organ	decreased testosterone by fetal Leydig cells	increased object quality
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:656	Cellular	Decreased number and function of adult Leydig cells	decreased process quality
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:656	Cellular	Decreased number and function of adult Leydig cells	increased object quality
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased object quality
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased amount
Aop:67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased quality
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome	Event:661	Molecular	Decreased testosterone by the fetal Leydig cells	deviation(from_normal)
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:655	Cellular	Decreased testosterone by the fetal Leydig cells	increased process quality
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:660	Organ	decreased testosterone by fetal Leydig cells	increased object quality
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:660	Organ	decreased testosterone by fetal Leydig cells	increased object quality
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:656	Cellular	Decreased number and function of adult Leydig cells	decreased process quality
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:656	Cellular	Decreased number and function of adult Leydig cells	increased object quality
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased object quality
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased amount
Aop:68	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis	Event:505	Individual	Decreased sperm quantity / quality in the adult	decreased quality
Aop:69	Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell	Event:642	Molecular	Decreased Cholesterol	decreased process quality
Aop:69	Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell	Event:643	Molecular	Decreased Cholesterol	decreased process quality
Aop:69	Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell	Event:644	Molecular	Decreased Cholesterol	decreased process quality
Aop:69	Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell	Event:645	Cellular	Decreased Cholesterol	decreased process quality
Aop:69	Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell	Event:646	Organ	Decreased Cholesterol	decreased amount
Aop:69	Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell	Event:646	Organ	Decreased Cholesterol	decreased quality
Aop:70	Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell	Event:640	Molecular	Decreased steroidogenesis	decreased process quality
Aop:70	Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell	Event:647	Cellular	Decreased steroidogenesis	decreased process quality
Aop:70	Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell	Event:648	Tissue	Decreased steroidogenesis	increased process quality
Aop:70	Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell	Event:649	Tissue	Decreased steroidogenesis	deviation(from_normal)
Aop:70	Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell	Event:520	Individual	Decreased sperm quantity or quality in the adult	decreased object quality
Aop:70	Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell	Event:520	Individual	Decreased sperm quantity or quality in the adult	decreased amount
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:650	Molecular	Stimulation of adult Leydig cells via the Adrenal Corticosterone	increased process quality
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:650	Molecular	Stimulation of adult Leydig cells via the Adrenal Corticosterone	increased process quality
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:525	Cellular	Apoptosis of adult Leydig cells	decreased concentration
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:525	Cellular	Apoptosis of adult Leydig cells	increased process quality
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:651	Cellular	Glucocorticoid Receptor mediated alterations in steriodogenic enzymes	deviation(from_normal)
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:652	Cellular	Direct effects of Corticosterone on steroidogenesis	deviation(from_normal)
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:520	Individual	Decreased sperm quantity or quality in the adult	decreased object quality
Aop:71	Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation	Event:520	Individual	Decreased sperm quantity or quality in the adult	decreased amount
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:526	Molecular	Inhibition	decreased process quality
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:528	Cellular	Decreased	decreased process quality
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:529	Molecular	Decreased	decreased process quality
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:530	Cellular	Decreased	decreased process quality
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:531	Cellular	Decreased	decreased concentration
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:532	Individual	Delayed	delayed
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:533	Cellular	Decreased	decreased process quality
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:534	Cellular	Altered	deviation(from_normal)
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:535	Cellular	Abnormal	deviation(from_normal)
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:536	Cellular	Altered	increased object quality
Aop:73	Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity	Event:527	Individual	Decreased	decreased object quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:662	Molecular	Decreased testosterone by the fetal Leydig cells	increased process quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:655	Cellular	Decreased testosterone by the fetal Leydig cells	increased process quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:540	Organ	Decreased testosterone by the fetal Leydig cells	increased object quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:540	Organ	Decreased testosterone by the fetal Leydig cells	increased object quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:541	Cellular	Decreased testosterone by the fetal Leydig cells	decreased process quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:541	Cellular	Decreased testosterone by the fetal Leydig cells	increased object quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:543	Individual	Decreased fertility in the adult	decreased object quality
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:543	Individual	Decreased fertility in the adult	decreased amount
Aop:74	Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis	Event:543	Individual	Decreased fertility in the adult	decreased quality
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:177	Cellular	N/A	damage
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 1	Event:1107	Population	"Weakened, Colony"	increased process quality
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 1	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 1	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:177	Cellular	N/A	damage
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:386	Organ	Decreased	decreased process quality
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:564	Population	Abnormal	deviation(from_normal)
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:565	Population	Reduced	decreased quality
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:566	Population	impaired	deviation(from_normal)
Aop:78	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:79	Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:79	Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure	Event:177	Cellular	N/A	damage
Aop:79	Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure	Event:568	Population	impaired	deviation(from_normal)
Aop:79	Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:79	Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:177	Cellular	N/A	damage
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:570	Cellular	Accumulation	damage
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:571	Individual	Accelerated	acceleration
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:664	Cellular	Overwhelmed	abnormal
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:572	Population	Decrease	decreased object quality
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:568	Population	impaired	deviation(from_normal)
Aop:80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:81	Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:81	Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure	Event:572	Population	Decrease	decreased object quality
Aop:81	Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure	Event:573	Individual	Increase	increased process quality
Aop:81	Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure	Event:573	Individual	Increase	increased process quality
Aop:81	Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure	Event:574	Individual	Increased	increased process quality
Aop:81	Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:82	Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure	Event:564	Population	Abnormal	deviation(from_normal)
Aop:82	Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure	Event:565	Population	Reduced	decreased quality
Aop:82	Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure	Event:566	Population	impaired	deviation(from_normal)
Aop:82	Abnormal roll change in worker caste contributes to reduced brood care and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:84	Suppression of immune system contributes to impaired development and leads to colony loss/failure	Event:572	Population	Decrease	decreased object quality
Aop:84	Suppression of immune system contributes to impaired development and leads to colony loss/failure	Event:576	Individual	Increased	increased object quality
Aop:84	Suppression of immune system contributes to impaired development and leads to colony loss/failure	Event:403	Individual	Suppression	increased process quality
Aop:84	Suppression of immune system contributes to impaired development and leads to colony loss/failure	Event:568	Population	impaired	deviation(from_normal)
Aop:84	Suppression of immune system contributes to impaired development and leads to colony loss/failure	Event:577	Individual	impaired	deviation(from_normal)
Aop:84	Suppression of immune system contributes to impaired development and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:85	Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:85	Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure	Event:572	Population	Decrease	decreased object quality
Aop:85	Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure	Event:576	Individual	Increased	increased object quality
Aop:85	Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure	Event:403	Individual	Suppression	increased process quality
Aop:85	Suppression of immune system contributes to abnormal foraging and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:564	Population	Abnormal	deviation(from_normal)
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:578	Molecular	Decreased	decreased process quality
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:579	Molecular	Decreased	decreased process quality
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:579	Molecular	Decreased	decreased process quality
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:561	Population	Reduced	decreased process quality
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:580	Population	Reduced	
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:566	Population	impaired	deviation(from_normal)
Aop:86	Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:177	Cellular	N/A	damage
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2	Event:1107	Population	"Weakened, Colony"	increased process quality
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2	Event:1108	Population	"Abnormal, Role change within caste"	
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 3	Event:663	Molecular	"Desensitization, Nicotinic acetylcholine receptor"	increased
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 3	Event:1107	Population	"Weakened, Colony"	increased
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 3	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:88	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 3	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:663	Molecular	Desensitization	increased process quality
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:663	Molecular	Desensitization	decreased process quality
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 4	Event:1107	Population	"Weakened, Colony"	increased process quality
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 4	Event:1108	Population	"Abnormal, Role change within caste"	
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 4	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:89	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 2	Event:1243	Cellular	"Altered, Ca2+-calmodulin activated signal transduction"	deviation(from_normal)
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:663	Molecular	Desensitization	increased process quality
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:663	Molecular	Desensitization	decreased process quality
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:564	Population	Abnormal	deviation(from_normal)
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:386	Organ	Decreased	decreased process quality
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:341	Individual	Impairment	decreased process quality
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:565	Population	Reduced	decreased quality
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:566	Population	impaired	deviation(from_normal)
Aop:90	Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:91	Sodium channel inhibition leading to reduced survival	Event:588	Population	Increased	increased process quality
Aop:91	Sodium channel inhibition leading to reduced survival	Event:584	Molecular	Inhibition	decreased process quality
Aop:91	Sodium channel inhibition leading to reduced survival	Event:585	Cellular	Inhibition	decreased process quality
Aop:91	Sodium channel inhibition leading to reduced survival	Event:586	Individual	Reduced	decreased speed
Aop:91	Sodium channel inhibition leading to reduced survival	Event:587	Individual	Reduced	decreased process quality
Aop:91	Sodium channel inhibition leading to reduced survival	Event:592	Population	Reduced	decreased object quality
Aop:93	sodium channel inhibition leading to increased predation	Event:588	Population	Increased	increased process quality
Aop:93	sodium channel inhibition leading to increased predation	Event:584	Molecular	Inhibition	decreased process quality
Aop:93	sodium channel inhibition leading to increased predation	Event:585	Cellular	Inhibition	decreased process quality
Aop:93	sodium channel inhibition leading to increased predation	Event:586	Individual	Reduced	decreased process quality
Aop:94	Sodium channel inhibition leading to congenital malformations	Event:444	Organ	Increased	increased process quality
Aop:94	Sodium channel inhibition leading to congenital malformations	Event:444	Organ	Increased	decreased process quality
Aop:94	Sodium channel inhibition leading to congenital malformations	Event:445	Organ	Increased	increased object quality
Aop:94	Sodium channel inhibition leading to congenital malformations	Event:591	Individual	Increased	
Aop:94	Sodium channel inhibition leading to congenital malformations	Event:584	Molecular	Inhibition	decreased process quality
Aop:94	Sodium channel inhibition leading to congenital malformations	Event:585	Cellular	Inhibition	decreased process quality
Aop:94	Sodium channel inhibition leading to congenital malformations	Event:590	Tissue	N/A	decreased object quality
Aop:95	Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival	Event:588	Population	Increased	increased process quality
Aop:95	Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival	Event:585	Cellular	Inhibition	decreased process quality
Aop:95	Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival	Event:593	Molecular	Inhibition	decreased process quality
Aop:95	Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival	Event:586	Individual	Reduced	decreased process quality
Aop:95	Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival	Event:587	Individual	Reduced	decreased process quality
Aop:95	Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival	Event:592	Population	Reduced	decreased object quality
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:351	Population	Increased	increased process quality
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:602	Organ	Increased	increased object quality
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:602	Organ	Increased	increased object quality
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:602	Organ	Increased	increased object quality
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:600	Molecular	Overactivation	increased process quality
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:601	Tissue	Overactivation	increased process quality
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:598	Molecular	modulation	deviation(from_normal)
Aop:96	Axonal sodium channel modulation leading to acute mortality	Event:599	Cellular	prolonged	increased duration
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation	Event:623	Population	Increase	increased behavioral activity
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation	Event:622	Individual	Increased	increased process quality
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation	Event:624	Individual	Increased	increased process quality
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation	Event:625	Organ	Increased	increased process quality
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to increased predation	Event:619	Molecular	Inhibition	decreased process quality
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline	Event:1139	Organ	"Increased, water retention in foot"	
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline	Event:361	Population	"Decline, Population"	decreased rate
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline	Event:1142	Tissue	"Increased, valve movement"	increased process quality
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline	Event:1143	Individual	"Depletion, energy reserves"	
Aop:97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline	Event:626	Cellular	"Increased, serotonin (5-HT)"	
Aop:98	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation	Event:627	Individual	Decreased	decreased process quality
Aop:98	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation	Event:629	Individual	Decreased	decreased object quality
Aop:98	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation	Event:588	Population	Increased	increased behavioral activity
Aop:98	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation	Event:626	Molecular	Increased	decreased process quality
Aop:98	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation	Event:619	Molecular	Inhibition	decreased process quality
Aop:99	Histamine (H2) receptor antagonism leading to reduced survival	Event:638	Molecular	Antagonism	decreased process quality
Aop:99	Histamine (H2) receptor antagonism leading to reduced survival	Event:633	Cellular	Decrease	decreased process quality
Aop:99	Histamine (H2) receptor antagonism leading to reduced survival	Event:635	Individual	Decreased	decreased process quality
Aop:99	Histamine (H2) receptor antagonism leading to reduced survival	Event:636	Population	Decreased	decreased object quality
Aop:99	Histamine (H2) receptor antagonism leading to reduced survival	Event:588	Population	Increased	increased behavioral activity
Aop:99	Histamine (H2) receptor antagonism leading to reduced survival	Event:634	Individual	N/A	increased object quality
Aop:99	Histamine (H2) receptor antagonism leading to reduced survival	Event:637	Individual	impaired	deviation(from_normal)
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:360	Individual	Decrease	decreased rate
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:79	Molecular	Inhibition	decreased process quality
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:79	Molecular	Inhibition	decreased process quality
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:671	Individual	Reduced	decreased object quality 
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:671	Individual	Reduced	decreased concentration
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:672	Organ	Reduced	decreased process quality
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:673	Individual	Reduced	abnormal
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:674	Individual	Reduced	decreased process quality
Aop:100	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior	Event:675	Individual	Reduced	decreased process quality
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:679	Population	Decline	decreased rate
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:681	Organ	Decreased	decreased process quality
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:79	Molecular	Inhibition	decreased process quality
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:79	Molecular	Inhibition	decreased process quality
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:671	Individual	Reduced	decreased object quality 
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:671	Individual	Reduced	decreased concentration
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:674	Individual	Reduced	decreased process quality
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:675	Individual	Reduced	decreased process quality
Aop:101	Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release	Event:678	Individual	Reduced	decreased process quality
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:679	Population	Decline	decreased rate
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:693	Tissue	Increased	increased concentration
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:79	Molecular	Inhibition	decreased process quality
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:79	Molecular	Inhibition	decreased process quality
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:675	Individual	Reduced	decreased process quality
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:687	Tissue	Reduced	decreased object quality 
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:687	Tissue	Reduced	decreased concentration
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:689	Tissue	Reduced	decreased object quality 
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:689	Tissue	Reduced	decreased concentration
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:690	Tissue	Reduced	decreased object quality 
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:690	Tissue	Reduced	decreased concentration
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:691	Tissue	Reduced	decreased concentration
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:692	Tissue	Reduced	decreased process quality
Aop:102	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition	Event:694	Cellular	Reduced	decreased process quality
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:696	Cellular	Increased	deviation(from_normal)
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:79	Molecular	Inhibition	decreased process quality
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:79	Molecular	Inhibition	decreased process quality
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:675	Individual	Reduced	decreased process quality
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:687	Tissue	Reduced	decreased object quality 
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:687	Tissue	Reduced	decreased concentration
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:689	Tissue	Reduced	decreased object quality 
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:689	Tissue	Reduced	decreased concentration
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:690	Tissue	Reduced	decreased object quality 
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:690	Tissue	Reduced	decreased concentration
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:691	Tissue	Reduced	decreased concentration
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:692	Tissue	Reduced	decreased process quality
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:686	Population	Declining	decreased rate
Aop:103	Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint	Event:695	Molecular	Upregulated	increased process quality
Aop:104	Altered ion channel activity leading impaired heart function	Event:698	Cellular	Altered	deviation(from_normal)
Aop:104	Altered ion channel activity leading impaired heart function	Event:351	Population	Increased	increased process quality
Aop:104	Altered ion channel activity leading impaired heart function	Event:699	Organ	Increased	increased object quality
Aop:104	Altered ion channel activity leading impaired heart function	Event:697	Cellular	impaired	decreased process quality
Aop:104	Altered ion channel activity leading impaired heart function	Event:697	Cellular	impaired	decreased process quality
Aop:105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:709	Cellular	Increase	increased process quality
Aop:105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:710	Cellular	Increase	increased process quality
Aop:105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:713	Tissue	Increase	increased object quality
Aop:105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:713	Tissue	Increase	increased object quality
Aop:105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:767	Cellular	Increase	increased process quality
Aop:105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:708	Tissue	Increased	increased concentration
Aop:105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:714	Molecular	Increased	increased process quality
Aop:106	Chemical binding to tubulin in oocytes leading to aneuploid offspring	Event:723	Cellular	Altered	increased object quality
Aop:106	Chemical binding to tubulin in oocytes leading to aneuploid offspring	Event:752	Cellular	Altered	deviation(from_normal)
Aop:106	Chemical binding to tubulin in oocytes leading to aneuploid offspring	Event:718	Molecular	Binding	increased process quality
Aop:106	Chemical binding to tubulin in oocytes leading to aneuploid offspring	Event:728	Individual	Increase	increased object quality
Aop:106	Chemical binding to tubulin in oocytes leading to aneuploid offspring	Event:720	Molecular	Depolymerization	increased process quality
Aop:106	Chemical binding to tubulin in oocytes leading to aneuploid offspring	Event:721	Cellular	Disorganization	decreased process quality
Aop:107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:715	Molecular	Activation	increased process quality
Aop:107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:716	Cellular	Increase	increased process quality
Aop:107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:774	Cellular	Increase	increased process quality
Aop:107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat	Event:1214	Cellular	"Altered gene expression specific to CAR activation, Hepatocytes"	
Aop:108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:209	Cellular	Increase	increased object quality
Aop:108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:768	Cellular	Increase	increased process quality
Aop:108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:769	Cellular	Increase	increased process quality
Aop:108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:726	Molecular	Increased	increased process quality
Aop:108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:724	Cellular	Inhibition	decreased process quality
Aop:109	Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)	Event:733	Cellular	Increase	increased process quality
Aop:109	Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)	Event:734	Cellular	Increase	increased process quality
Aop:109	Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)	Event:735	Cellular	Increase	increased process quality
Aop:109	Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)	Event:736	Tissue	Increase	increased object quality
Aop:109	Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)	Event:736	Tissue	Increase	increased object quality
Aop:109	Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)	Event:770	Cellular	Increase	increased process quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:771	Tissue	Decrease	decreased object quality 
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:771	Tissue	Decrease	decreased concentration
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:737	Cellular	Decreased	decreased process quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:739	Cellular	Increase	increased object quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:739	Cellular	Increase	increased object quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:740	Cellular	Increase	increased process quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:741	Tissue	Increase	increased object quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:741	Tissue	Increase	increased object quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:753	Tissue	Increase	increased object quality
Aop:110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:753	Tissue	Increase	increased concentration
Aop:111	Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)	Event:742	Molecular	Decreased	decreased process quality
Aop:111	Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)	Event:743	Molecular	Decreased	decreased process quality
Aop:111	Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)	Event:744	Cellular	Increase	increased process quality
Aop:111	Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)	Event:745	Cellular	Increase	increased object quality
Aop:111	Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)	Event:754	Tissue	Increased	increased object quality
Aop:111	Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)	Event:754	Tissue	Increased	increased concentration
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:747	Tissue	Decreased	decreased object quality 
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:747	Tissue	Decreased	decreased concentration
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:749	Tissue	Decreased	decreased object quality 
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:749	Tissue	Decreased	decreased concentration
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:746	Cellular	Increase	increased process quality
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:746	Cellular	Increase	increased process quality
	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:746	Cellular	Increase	increased process quality
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:772	Cellular	Increase	increased process quality
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:773	Tissue	Increase	increased object quality
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:773	Tissue	Increase	increased object quality
Aop:112	Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)	Event:748	Molecular	Increased	increased process quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:760	Molecular	Activation	increased process quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:765	Population	Decreased	decreased quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:351	Population	Increased	increased process quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:761	Cellular	Increased	increased process quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:764	Organ	N/A	increased object quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:764	Organ	N/A	increased object quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:764	Organ	N/A	increased object quality
Aop:113	Glutamate-gated chloride channel activation leading to acute mortality	Event:763	Cellular	hyperpolarisation	increased process quality
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:776	Cellular	Increase	increased process quality
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:777	Cellular	Increase	increased object  quality
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:778	Cellular	Increase	increased process quality
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:779	Cellular	Increase	increased object quality
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:779	Cellular	Increase	increased object quality
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:775	Tissue	Increased	decreased object quality 
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:775	Tissue	Increased	increased process quality
Aop:114	HPPD inhibition leading to corneal papillomas and carcinomas (in rat)	Event:766	Molecular	Inhibition	decreased process quality
Aop:115	Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)	Event:149	Cellular	Increase	increased process quality
Aop:115	Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)	Event:779	Cellular	Increase	increased object quality
Aop:115	Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)	Event:779	Cellular	Increase	increased object quality
Aop:115	Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)	Event:780	Cellular	Increase	increased process quality
Aop:115	Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)	Event:781	Cellular	Increase	
Aop:115	Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)	Event:782	Cellular	Increase	
Aop:116	Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:710	Cellular	Increase	increased process quality
Aop:116	Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:713	Tissue	Increase	increased object quality
Aop:116	Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:713	Tissue	Increase	increased object quality
Aop:116	Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:783	Cellular	Increase	increased process quality
Aop:116	Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)	Event:784	Cellular	Increase	increased process quality
Aop:117	Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:785	Molecular	Activation	increased process quality
Aop:117	Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:716	Cellular	Increase	increased process quality
Aop:117	Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:117	Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:117	Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:774	Cellular	Increase	increased process quality
Aop:118	Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:118	Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:719	Tissue	Increase	increased object quality
Aop:118	Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:774	Cellular	Increase	increased process quality
Aop:118	Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:786	Cellular	Increase	increased process quality
Aop:118	Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat)	Event:787	Cellular	Increase	increased process quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:771	Tissue	Decrease	decreased object quality 
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:771	Tissue	Decrease	decreased concentration
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:788	Cellular	Decrease	decreased process quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:739	Cellular	Increase	increased object quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:739	Cellular	Increase	increased object quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:740	Cellular	Increase	increased process quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:741	Tissue	Increase	increased object quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:741	Tissue	Increase	increased object quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:753	Tissue	Increase	increased object quality
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:753	Tissue	Increase	increased concentration
Aop:119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)	Event:279	Molecular	Inhibition	decreased process quality
Aop:120	Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat)	Event:792	Tissue	Decrease	decreased object quality 
Aop:120	Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat)	Event:792	Tissue	Decrease	decreased concentration
Aop:120	Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat)	Event:744	Cellular	Increase	increased process quality
Aop:120	Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat)	Event:745	Cellular	Increase	increased object quality
Aop:120	Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat)	Event:791	Tissue	Increased	decreased object quality 
Aop:120	Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat)	Event:791	Tissue	Increased	increased concentration
Aop:120	Inhibition of 5alpha-reductase leading to Leydig cell tumors (in rat)	Event:790	Cellular	Inhibition	decreased process quality
Aop:121	Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)	Event:793	Organ	Increase	increased object quality
Aop:121	Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)	Event:794	Cellular	Increase	increased process quality
Aop:121	Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)	Event:795	Cellular	Increase	increased object quality
Aop:121	Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)	Event:796	Cellular	Increase	increased process quality
Aop:121	Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)	Event:797	Tissue	Increase	increased object quality
Aop:121	Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)	Event:797	Tissue	Increase	increased object quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:360	Individual	Decrease	decreased rate
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:800	Cellular	Decreased	decreased process quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:799	Cellular	Increased	increased process quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:798	Cellular	Inhibition	decreased process quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:3	Cellular	Reduction	decreased process quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:78	Individual	Reduction	decreased amount
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:219	Organ	Reduction	decreased object quality 
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:219	Organ	Reduction	decreased concentration
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:221	Organ	Reduction	decreased concentration
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:221	Organ	Reduction	decreased concentration
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:285	Tissue	Reduction	increased process quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:309	Cellular	Reduction	decreased process quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:309	Cellular	Reduction	decreased process quality
Aop:122	Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation	Event:309	Cellular	Reduction	decreased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:360	Population	Decrease	decreased rate
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:800	Cellular	Decreased	decreased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:799	Cellular	Increased	increased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:802	Cellular	Increased	increased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:3	Cellular	Reduction	decreased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:78	Individual	Reduction	decreased amount
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:219	Organ	Reduction	decreased object quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:219	Organ	Reduction	decreased concentration
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:221	Organ	Reduction	decreased concentration
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:221	Organ	Reduction	decreased concentration
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:285	Tissue	Reduction	Increased
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:309	Cellular	Reduction	decreased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:309	Cellular	Reduction	decreased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:309	Cellular	Reduction	decreased process quality
Aop:123	Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription	Event:801	Molecular	modulation	deviation(from_normal)
Aop:124	HMG-CoA reductase inhibition leading to decreased fertility	Event:330	Individual	Decreased	decreased object quality
Aop:124	HMG-CoA reductase inhibition leading to decreased fertility	Event:805	Cellular	Decreased	decreased object quality
Aop:124	HMG-CoA reductase inhibition leading to decreased fertility	Event:807	Cellular	Decreased	decreased object quality
Aop:124	HMG-CoA reductase inhibition leading to decreased fertility	Event:808	Individual	Decreased	decreased object quality
Aop:124	HMG-CoA reductase inhibition leading to decreased fertility	Event:808	Individual	Decreased	decreased concentration
Aop:124	HMG-CoA reductase inhibition leading to decreased fertility	Event:804	Cellular	Inhibition	decreased process quality
Aop:124	HMG-CoA reductase inhibition leading to decreased fertility	Event:809	Individual	malformed	deviation(from_normal)
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:535	Cellular	Abnormal	deviation(from_normal)
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:534	Cellular	Altered	deviation(from_normal)
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:536	Cellular	Altered	increased object quality
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:527	Individual	Decreased	decreased object quality
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:529	Molecular	Decreased	decreased process quality
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:530	Cellular	Decreased	decreased process quality
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:531	Cellular	Decreased	decreased concentration
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:533	Cellular	Decreased	decreased process quality
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:848	Cellular	Decreased	decreased process quality
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:849	Molecular	Inhibition	decreased process quality
Aop:126	Alpha-noradrenergic antagonism leads to reduced fecundity via delayed ovulation	Event:532	Individual	Delayed	delayed
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:277	Molecular	Decreased	decreased process quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:426	Tissue	Decreased	decreased object quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:426	Tissue	Decreased	decreased concentration
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:819	Tissue	Decreased	decreased process quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:820	Tissue	Decreased	decreased process quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:821	Organ	Decreased	decreased process quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:825	Organ	Decreased	decreased process quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:813	Organ	Increased	increased object quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:813	Organ	Increased	increased object quality
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:814	Organ	Occurrence	occurrence
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:818	Organ	Occurrence	occurrence
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:823	Organ	Occurrence	occurrence
Aop:128	Kidney dysfunction by decreased thyroid hormone	Event:824	Organ	Occurrence	occurrence
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:829	Cellular	Damage	damage
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:839	Cellular	Formation	increased process quality
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:840	Tissue	Formation	increased object quality
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:838	Tissue	Induction	increased object quality
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:828	Molecular	Inhibition	decreased process quality
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:833	Cellular	Occurrence	occurrence
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:835	Cellular	Occurrence	occurrence
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:836	Cellular	Occurrence	occurrence
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:837	Cellular	Occurrence	occurrence
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:831	Cellular	Disturbance	damage
Aop:130	Phospholipase A inhibitors lead to hepatotoxicity	Event:832	Cellular	Injury	damage
Aop:131	AhR activation leading to uroporphyria	Event:846	Organ	Accumulation	Accumulation
Aop:131	AhR activation leading to uroporphyria	Event:846	Organ	Accumulation	Accumulation
Aop:131	AhR activation leading to uroporphyria	Event:18	Molecular	Activation	increased process quality
Aop:131	AhR activation leading to uroporphyria	Event:850	Molecular	Induction	increased process quality
Aop:131	AhR activation leading to uroporphyria	Event:850	Molecular	Induction	increased process quality
Aop:131	AhR activation leading to uroporphyria	Event:845	Molecular	Inhibition	decreased process quality
Aop:131	AhR activation leading to uroporphyria	Event:369	Individual	N/A	increased object quality
Aop:131	AhR activation leading to uroporphyria	Event:844	Cellular	Oxidation	increased process quality
Aop:131	AhR activation leading to uroporphyria	Event:844	Cellular	Oxidation	increased process quality
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:756	Tissue	Altered	deviation(from_normal)
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:757	Organ	Altered	malformed
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:277	Molecular	Decreased	decreased process quality
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:280	Organ	Decreased	decreased concentration
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:281	Tissue	Decreased	decreased concentration
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:402	Individual	Decreased	decreased process quality
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:402	Individual	Decreased	decreased process quality
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:425	Cellular	Decreased	decreased process quality
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:758	Tissue	Decreased	abnormal
Aop:134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals	Event:424	Molecular	Inhibition	decreased process quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:867	Cellular	Decrease	decreased process quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:768	Cellular	Increase	increased process quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:868	Tissue	Increase	increased process quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:868	Tissue	Increase	increased object quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:869	Tissue	Increase	increased process quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:869	Tissue	Increase	increased process quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:870	Cellular	Increase	increased process quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:872	Organ	Increase	increased object quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:872	Organ	Increase	increased object quality
Aop:136	Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors	Event:876	Molecular	Increase	increased process quality
Aop:138	p-amino hippuric acid channel (PAH) inhibition leading to renal failure and mortality	Event:877	Molecular	Inhibition	decreased process quality
Aop:138	p-amino hippuric acid channel (PAH) inhibition leading to renal failure and mortality	Event:877	Molecular	Inhibition	decreased process quality
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:1096	Tissue	"Increased, blood uric acid concentration"	
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:1097	Tissue	"Occurrence, renal proximal tubular necrosis"	
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:1098	Tissue	"Increased, blood potassium concentration"	
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:351	Population	"Increased, Mortality"	increased
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:361	Population	"Decline, Population"	decreased rate
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:1102	Tissue	"Occurrence, tophi (urate) deposition"	
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:1106	Organ	"Occurrence, cardiac arrhythmia"	
Aop:138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality	Event:1088	Cellular	"Increased, Oxidative Stress"	
Aop:139	Alkylation of DNA leading to cancer	Event:185	Molecular	Increase	increased process quality
Aop:139	Alkylation of DNA leading to cancer	Event:885	Tissue	Increase	increased object quality
Aop:139	Alkylation of DNA leading to cancer	Event:155	Cellular	N/A	insufficient
Aop:141	Alkylation of DNA leading to cancer	Event:97	Molecular	Alkylation	increased process quality
Aop:141	Alkylation of DNA leading to cancer	Event:185	Molecular	Increase	increased process quality
Aop:141	Alkylation of DNA leading to cancer	Event:885	Tissue	Increase	increased object quality
Aop:141	Alkylation of DNA leading to cancer	Event:155	Cellular	N/A	insufficient
Aop:144	Lysosomal damage leading to liver inflammation	Event:898	Cellular	Disruption	occurrence
Aop:144	Lysosomal damage leading to liver inflammation	Event:209	Cellular	Increase	increased object quality
Aop:144	Lysosomal damage leading to liver inflammation	Event:902	Organ	Inflammation	increased object quality
Aop:144	Lysosomal damage leading to liver inflammation	Event:55	Cellular	N/A	increased process quality
Aop:144	Lysosomal damage leading to liver inflammation	Event:177	Cellular	N/A	damage
Aop:144	Lysosomal damage leading to liver inflammation	Event:87	Cellular	Release	increased process quality
Aop:144	Lysosomal damage leading to liver inflammation	Event:901	Tissue	Infiltration	increased process quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:924	Molecular	Activation	increased process quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:941	Molecular	Activation	increased process quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:914	Cellular	Decrease	decreased process quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:919	Cellular	Increase	increased process quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:920	Tissue	Increase	increased object quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:921	Tissue	Increase	increased process quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:923	Cellular	Increase	increased process quality
Aop:148	EGFR Activation Leading to Mucus Hypersecretion	Event:962	Cellular	Increase	increased process quality
Aop:148	EGFR Activation Leading to Decreased Lung Function	Event:1250	Individual	"Decrease, Lung function"	
Aop:148	EGFR Activation Leading to Decreased Lung Function	Event:1251	Tissue	"Chronic, Mucus hypersecretion"	
Aop:149	Oxidative Stress Leading to Hypertension	Event:934	Cellular	Decrease	decreased object quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:935	Cellular	Decrease	decreased object quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:973	Cellular	Decrease	decreased process quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:973	Cellular	Decrease	decreased process quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:933	Cellular	Depletion	decreased concentration
Aop:149	Oxidative Stress Leading to Hypertension	Event:209	Cellular	Increase	increased object quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:951	Organ	Increase	increased process quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:952	Individual	N/A	increased process quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:937	Organ	impaired	deviation(from_normal)
Aop:149	Oxidative Stress Leading to Hypertension	Event:926	Molecular	Oxidation	deviation(from_normal)
Aop:149	Oxidative Stress Leading to Hypertension	Event:927	Molecular	S-Glutathionylation	increased process quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:927	Molecular	S-Glutathionylation	increased process quality
Aop:149	Oxidative Stress Leading to Hypertension	Event:932	Cellular	Uncoupling	
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:18	Molecular	Activation	increased process quality
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:317	Organ	Altered	deformed
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:317	Organ	Altered	deformed
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:110	Tissue	Impairment	deviation(from_normal)
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:358	Organ	Increase	increased object quality
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:947	Individual	Increase	increased object quality
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:948	Cellular	reduced production	decreased process quality
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:944	Molecular	dimerization	temporal distribution quality
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:944	Molecular	dimerization	temporal distribution quality
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:945	Molecular	reduced dimerization	decreased process quality
Aop:150	Aryl hydrocarbon receptor activation leading to embryolethality via cardiotoxicty	Event:945	Molecular	reduced dimerization	decreased process quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:756	Tissue	Altered	deviation(from_normal)
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:757	Organ	Altered	abnormal
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:957	Molecular	Binding	increased process quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:280	Organ	Decreased	decreased concentration
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:280	Organ	Decreased	decreased concentration
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:281	Tissue	Decreased	decreased object quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:281	Tissue	Decreased	decreased concentration
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:402	Individual	Decreased	decreased process quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:758	Tissue	Decreased	decreased process quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:959	Tissue	Increased	increased object quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:959	Tissue	Increased	increased concentration
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:960	Cellular	Increased	increased process quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:961	Tissue	Increased	increased process quality
Aop:152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity	Event:958	Molecular	Displacement	increased concentration
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:972	Individual	Decreased fertility	decreased amount
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:964	Molecular	Inhibition of Aromatase Enzyme	decreased process quality
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:965	Cellular	reduction in ovarian granulosa cells synthesis of estradiol	decreased process quality
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:966	Tissue	Reduced Estradiol in Circulation	decreased object quality
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:966	Tissue	Reduced Estradiol in Circulation	decreased concentration
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:966	Tissue	Reduced Estradiol in Circulation	decreased object quality
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:967	Organ	Decreased positive estrogenic feedback on hypothalamus	decreased concentration
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:968	Cellular	Decreased Kisspeptin release from neurons in AVPV	decreased process quality
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:969	Cellular	Decreased GnRH Release	decreased process quality
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:970	Cellular	Decreased LH release from Anterior Pituitary	decreased process quality
Aop:153	Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats	Event:971	Individual	"Ovulation of oocytes Reduced, Delayed, or Blocked"	deviation(from_normal)
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:986	Individual	Increase	increased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:979	Molecular	Inhibition	increased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:981	Cellular	Suppression	decreased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:981	Cellular	Suppression	increased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:984	Individual	Suppression	increased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:980	Molecular	"Binding, Formation"	increased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:980	Molecular	"Binding, Formation"	increased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:985	Individual	Relief	decreased process quality
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:986	Individual	"Increase, Increased susceptibility to infection"	increased
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:1201	Molecular	"Formation, Binding of FK506 to FKBP12"	
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:1202	Molecular	"Activation, Hampered NFAT activation and following nuclear localization"	
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:1203	Tissue	"Suppression, Suppression of production of cytotoxic T-cells"	
Aop:154	The Adverse Outcome Pathway on binding of FK506-binding protein 12 (FKBP12) by calcineurin inhibitors leading to immunosuppression	Event:1204	Cellular	"Suppression, Suppression of T-cell dependent antibody production"	
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:360	Population	Decrease	decreased rate
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased object quality
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased concentration
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1002	Cellular	Inhibition	decreased process quality
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1004	Organ	Reduced	decreased process quality
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1005	Individual	Reduced	decreased process quality
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1006	Individual	Reduced	decreased object quality
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1007	Organ	Reduced	decreased process quality
Aop:155	Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1008	Organ	Reduced	decreased process quality
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:360	Population	Decrease	decreased rate
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased object quality
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased concentration
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1002	Cellular	Inhibition	decreased process quality
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1005	Individual	Reduced	decreased process quality
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1006	Individual	Reduced	decreased object quality
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1007	Organ	Reduced	decreased process quality
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1008	Organ	Reduced	decreased process quality
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:360	Population	Decrease	decreased rate
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased object quality
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased concentration
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1009	Cellular	Inhibition	decreased process quality
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1004	Organ	Reduced	decreased process quality
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1005	Individual	Reduced	decreased process quality
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1006	Individual	Reduced	decreased object quality
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1007	Organ	Reduced	decreased process quality
Aop:157	Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation	Event:1008	Organ	Reduced	decreased process quality
Aop:158	Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:360	Population	Decrease	decreased rate
Aop:156	Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased object quality
Aop:158	Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1003	Tissue	Decreased	decreased concentration
Aop:158	Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1009	Cellular	Inhibition	decreased process quality
Aop:158	Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1005	Individual	Reduced	decreased process quality
Aop:158	Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1006	Individual	Reduced	decreased object quality
Aop:158	Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1007	Organ	Reduced	decreased process quality
Aop:158	Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1008	Organ	Reduced	decreased process quality
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:360	Population	Decrease	decreased rate
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:277	Molecular	Decreased	decreased process quality
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:281	Tissue	Decreased	decreased object quality
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:281	Tissue	Decreased	decreased concentration
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:279	Molecular	Inhibition	decreased process quality
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1005	Individual	Reduced	decreased process quality
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1006	Individual	Reduced	decreased object quality
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1007	Organ	Reduced	decreased process quality
Aop:159	Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation	Event:1008	Organ	Reduced	decreased process quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:762	Molecular	Activation	increased process quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:351	Population	Increased	increased process quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:761	Cellular	Increased	increased process quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:1012	Cellular	Increased	increased process quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:1015	Cellular	Increased	decreased process quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:1014	Tissue	Induction	increased object quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:1014	Tissue	Induction	increased object quality
Aop:160	Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality	Event:1016	Individual	Inhibition	decreased process quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:1018	Molecular	Activation	increased process quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:351	Individual	Increased	increased process quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:761	Cellular	Increased	increased process quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:1012	Cellular	Increased	increased process quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:1015	Cellular	Increased	decreased process quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:1019	Tissue	Induction	increased object quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:1019	Tissue	Induction	increased object quality
Aop:161	Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality	Event:1016	Individual	Inhibition	decreased process quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1020	Cellular	Increased	increased process quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1021	Cellular	Increased	increased process quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1022	Tissue	Decreased	decreased object quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1022	Tissue	Decreased	decreased concentration
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1023	Tissue	Increased	increased object quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1023	Tissue	Increased	increased concentration
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1024	Cellular	Increased	increased object quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1024	Cellular	Increased	increased object quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1025	Tissue	Increased	increased process quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1026	Tissue	Increased Apoptosis	increased object quality
Aop:162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas (in rat and mouse)	Event:1026	Tissue	Increased Apoptosis	increased object quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1028	Molecular	Activation of specific nuclear receptors	decreased process quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1029	Cellular	Increased	increased process quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1032	Cellular	Increased	increased process quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1033	Cellular	Increased	increased process quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1034	Cellular	Increased	increased process quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1035	Tissue	Increased	increased process quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1036	Tissue	Increased	increased process quality
Aop:163	"PPARgamma activation leading to sarcomas in rats, mice, and hamsters"	Event:1037	Tissue	Increased	increased process quality
Aop:164	Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse	Event:1038	Molecular	Activation	increased process quality
Aop:164	Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse	Event:1039	Molecular	Increased activity	increased process quality
Aop:164	Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse	Event:1040	Tissue	relaxation	increased process quality
Aop:164	Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse	Event:1042	Cellular	Proliferation/Clonal Expansion	increased process quality
Aop:164	Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse	Event:1043	Cellular	Hypertrophy/hyperplasia	increased process quality
Aop:164	Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse	Event:1044	Tissue	Promotion	increased object quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1045	Tissue	Decreased	decreased object quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1045	Tissue	Decreased	decreased concentration
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1046	Molecular	Suppression	decreased process quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1047	Cellular	Increased	decreased process quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1049	Cellular	Increased	decreased process quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1050	Cellular	Increased	decreased process quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1051	Cellular	Hyperplasia	increased process quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1052	Tissue	Hyperplasia	increased process quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1053	Tissue	Promotion	increased object quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1053	Tissue	Promotion	increased object quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1054	Cellular	Promotion	increased object quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1054	Cellular	Promotion	increased object quality
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1056	Tissue	Decrease	decreased object quality 
Aop:165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse	Event:1056	Tissue	Decrease	decreased concentration
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1057	Molecular	Increased	decreased process quality
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1058	Organ	Decreased	decreased amount
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1059	Organ	Increased	occurrence
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1060	Cellular	Alteration	deviation(from_normal)
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1061	Tissue	prolonged	increased object quality
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1061	Tissue	prolonged	increased object quality
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1062	Cellular	Increased	increased object quality
Aop:166	PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse	Event:1063	Organ	Increased	increased object quality
Aop:167	Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.	Event:1064	Molecular	prepubertal increase	decreased process quality
Aop:167	Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.	Event:1065	Molecular	Activation	increased process quality
Aop:167	Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.	Event:1066	Cellular	Promotion	increased process quality
Aop:167	Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.	Event:1067	Cellular	Proliferation/Clonal Expansion	increased process quality
Aop:167	Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.	Event:1068	Tissue	squamous metaplasia	deformed
Aop:167	Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.	Event:1069	Cellular	Increased	increased process quality
Aop:167	Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.	Event:1070	Tissue	Increased	increased object quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1071	Cellular	Decreased	decreased process quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1072	Cellular	Decreased	decreased process quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1074	Individual	interruption	disrupted
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1075	Individual	prolonged	delayed
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1076	Organ	Increased	increased object quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1076	Organ	Increased	increased concentration
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1077	Tissue	Increased	increased object quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1077	Tissue	Increased	increased concentration
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1078	Tissue	Hyperplasia	increased process quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1079	Tissue	Increased	increased object quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1079	Tissue	Increased	increased object quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1079	Tissue	Increased	increased object quality
Aop:168	GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.	Event:1080	Individual	Increased	increased object quality
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1071	Cellular	Decreased	decreased process quality
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1072	Cellular	Decreased	decreased process quality
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1075	Individual	prolonged	delayed
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1074	Individual	interruption	disrupted
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1076	Organ	Increased	increased object quality
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1076	Organ	Increased	increased concentration
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1081	Cellular	Increased	increased process quality
Aop:169	GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.	Event:1082	Tissue	Increased	increased object quality
Aop:170	Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat	Event:1083	Cellular	Decreased	increased process quality
Aop:170	Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat	Event:1084	Tissue	Increased	increased object quality
Aop:170	Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat	Event:1085	Tissue	Increased	increased process quality
Aop:170	Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat	Event:1080	Individual	Increased	increased object quality
Aop:170	Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat	Event:1079	Tissue	Increased	increased object quality
Aop:170	Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat	Event:1079	Tissue	Increased	increased object quality
Aop:170	Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the rat	Event:1079	Tissue	Increased	increased object quality
Aop:171	Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.	Event:1086	Cellular	persistent	increased process quality
Aop:171	Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.	Event:1087	Cellular	Increased	increased process quality
Aop:171	Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.	Event:1088	Cellular	Increased	increased object quality
Aop:171	Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.	Event:1032	Cellular	Increased	increased process quality
Aop:171	Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.	Event:1089	Cellular	Increased	increased process quality
Aop:171	Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.	Event:1090	Tissue	Increased	increased object quality
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:279	Molecular	Inhibition	decreased process quality
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:277	Molecular	Decreased	decreased process quality
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:281	Tissue	Decreased	decreased concentration
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	increased object quality
Aop:175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	increased object quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:424	Molecular	Inhibition	decreased process quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:425	Cellular	Decreased	decreased process quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:277	Molecular	Decreased	decreased process quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:281	Tissue	Decreased	decreased concentration
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	increased object quality
Aop:176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	increased object quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1104	Tissue	Decreased	decreased concentration
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1104	Tissue	Decreased	decreased object quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1105	Tissue	Occurrence	occurrence
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1097	Tissue	Occurrence	occurrence
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1098	Tissue	Increased	increased object quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1098	Tissue	Increased	increased object quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:351	Individual	Increased	increased process quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:361	Population	Decline	decreased rate
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1103	Molecular	Inhibition	decreased process quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1106	Organ	Occurrence	increased object quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1088	Cellular	Increased	increased process quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1096	Tissue	Increased	increased object quality
Aop:177	Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality	Event:1102	Tissue	Occurrence	increased object quality
Aop:178	Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure	Event:559	Molecular	Activation	increased process quality
Aop:178	Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure	Event:177	Cellular	N/A	damage
Aop:178	Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:178	Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:179	Varroa mite infestation increases virus levels leading to colony loss/failure	Event:1109	Individual	Increased	increased object quality
Aop:179	Varroa mite infestation increases virus levels leading to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:179	Varroa mite infestation increases virus levels leading to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:180	Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:180	Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:180	Varroa mite infestation contributes to abnormal foraging leading to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:181	Weather event contributes to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:181	Weather event contributes to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:182	Weather event contributes abnormal foraging leading to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:182	Weather event contributes abnormal foraging leading to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:182	Weather event contributes abnormal foraging leading to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:183	Nosema infection increases energetic demands leading to colony loss/failure	Event:1110	Individual	Increased	increased process quality
Aop:183	Nosema infection increases energetic demands leading to colony loss/failure	Event:1110	Individual	Increased	increased process quality
Aop:183	Nosema infection increases energetic demands leading to colony loss/failure	Event:560	Individual	Abnormal	deviation(from_normal)
Aop:183	Nosema infection increases energetic demands leading to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:183	Nosema infection increases energetic demands leading to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:184	Nosema infection causes abnormal role change that leads to colony loss/failure	Event:1108	Population	Abnormal	abnormal
Aop:184	Nosema infection causes abnormal role change that leads to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:184	Nosema infection causes abnormal role change that leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:185	Queen egg-laying decrease leads to colony loss/failure	Event:1107	Population	Weakened	increased process quality
Aop:185	Queen egg-laying decrease leads to colony loss/failure	Event:563	Population	Loss/Failure	increased process quality
Aop:186	unknown MIE leading to renal failure and mortality	Event:1114	Molecular	Unknown	
Aop:186	unknown MIE leading to renal failure and mortality	Event:1115	Cellular	Increased	increased object quality
Aop:186	unknown MIE leading to renal failure and mortality	Event:1088	Cellular	Increased	increased object quality
Aop:186	unknown MIE leading to renal failure and mortality	Event:1097	Tissue	Occurrence	occurrence
Aop:186	unknown MIE leading to renal failure and mortality	Event:1098	Tissue	Increased	increased object quality
Aop:186	unknown MIE leading to renal failure and mortality	Event:1098	Tissue	Increased	increased object quality
Aop:186	unknown MIE leading to renal failure and mortality	Event:1106	Organ	Occurrence	increased object quality
Aop:186	unknown MIE leading to renal failure and mortality	Event:351	Individual	Increased	increased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1122	Tissue	Under carboxylated clotting factors will not assemble on cell surfaces to form clot	deviation(from_normal)
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1130	Organ	Failure in vascular repair mechanisms	increased object quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1130	Organ	Failure in vascular repair mechanisms	deviation(from_normal)
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1131	Molecular	"Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X"	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1131	Molecular	"Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X"	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1131	Molecular	"Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X"	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1131	Molecular	"Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X"	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1132	Cellular	Blood loss and development of anemia	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1132	Cellular	Blood loss and development of anemia	deviation(from_normal)
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1132	Cellular	Blood loss and development of anemia	pathological
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1133	Tissue	Hemostasis	decreased object quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1133	Tissue	Hemostasis	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1134	Molecular	Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139	deviation(from_normal)
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1134	Molecular	Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1134	Molecular	Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1135	Tissue	Reduced fitness or even mortality	
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1135	Tissue	Reduced fitness or even mortality	
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1135	Tissue	Reduced fitness or even mortality	non-functional
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1135	Tissue	Reduced fitness or even mortality	decreased object quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1135	Tissue	Reduced fitness or even mortality	increased object quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1136	Population	Impaired recruitment	decreased rate
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1138	Molecular	Uncoupling of oxidative phosphorylation	decreased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1138	Molecular	Uncoupling of oxidative phosphorylation	increased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1151	Individual	Osteoporosis and vascular calcification	increased object quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1151	Individual	Osteoporosis and vascular calcification	increased process quality
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1169	Molecular	Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone	deviation(from_normal)
Aop:187	Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage	Event:1169	Molecular	Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone	decreased process quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:1152	Molecular	Inhibition	decreased process quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:425	Cellular	Decreased	decreased process quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:277	Molecular	Decreased	decreased process quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:426	Tissue	Decreased	decreased object quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:426	Tissue	Decreased	decreased concentration
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	increased object quality
Aop:188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:189	Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis	Event:1009	Molecular	Inhibition	decreased process quality
Aop:189	Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:189	Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased concentration
Aop:189	Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis	Event:1003	Cellular	Decreased	decreased object quality
Aop:189	Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis	Event:1003	Cellular	Decreased	decreased concentration
Aop:189	Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:190	Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis	Event:1002	Molecular	Inhibition	decreased process quality
Aop:190	Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:190	Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:190	Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:191	Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis	Event:1153	Molecular	Inhibition	decreased process quality
Aop:191	Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis	Event:1154	Tissue	Increased	decreased object quality
Aop:191	Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis	Event:1154	Tissue	Increased	decreased object quality
Aop:191	Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:1155	Molecular	Inhibition	decreased process quality
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:277	Molecular	Decreased	decreased process quality
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:426	Tissue	Decreased	decreased object quality
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:426	Tissue	Decreased	decreased concentration
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	decreased object quality
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	decreased concentration
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased concentration
Aop:192	Pendrin inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:1156	Molecular	Inhibition	decreased process quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:277	Molecular	Decreased	decreased process quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:426	Tissue	Decreased	decreased object quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:426	Tissue	Decreased	decreased concentration
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	increased object quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:1157	Molecular	Activation	increased process quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:1158	Tissue	Increased	increased process quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:295	Molecular	Induction	increased process quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:401	Organ	Increase	increased process quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:281	Tissue	Decreased	decreased object quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:281	Tissue	Decreased	decreased concentration
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	decreased object quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:1093	Tissue	Decreased	decreased object quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased object quality
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:1116	Tissue	Decreased	decreased concentration
Aop:194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis	Event:1101	Organ	Altered	increased process quality
Aop:195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase	Event:619	Molecular	Inhibition	decreased process quality
Aop:195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase	Event:626	Molecular	Increased	decreased process quality
Aop:195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase	Event:1161	Organ	Increased	increased process quality
Aop:195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase	Event:1163	Individual	Increased	increased process quality
Aop:195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase	Event:1164	Population	Increased	increased object quality
Aop:195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase	Event:1255	Individual	induced spawning	
Aop:195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase	Event:1142	Tissue	"Increased, valve movement"	
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1215	Molecular	TRPA1 activation	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1218	Cellular	Opening of calcium channel	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1220	Cellular	Excitation	decreased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1222	Cellular	SP (Substance P) release	increased amount
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1223	Tissue	"Airway Hyper-responsiveness,Cough, Dyspnea"	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1223	Tissue	"Airway Hyper-responsiveness,Cough, Dyspnea"	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1223	Tissue	"Airway Hyper-responsiveness,Cough, Dyspnea"	increased object quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1223	Tissue	"Airway Hyper-responsiveness,Cough, Dyspnea"	increased object quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1223	Tissue	"Airway Hyper-responsiveness,Cough, Dyspnea"	increased object quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1224	Individual	Non-neuronal production of TNF	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1224	Individual	Non-neuronal production of TNF	increased object quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1225	Tissue	Leukocyte infiltration	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1225	Tissue	Leukocyte infiltration	increased object quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1226	Individual	Chronic Cough	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1226	Individual	Chronic Cough	increased object quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1230	Molecular	TRPV1 activation	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1234	Tissue	Production of nerve growth factor	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1234	Tissue	Production of nerve growth factor	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1235	Tissue	Non-neuronal production of IL-8/CXCL1	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1235	Tissue	Non-neuronal production of IL-8/CXCL1	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1235	Tissue	Non-neuronal production of IL-8/CXCL1	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1236	Cellular	Generation of novel epitopes	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1237	Individual	Sensitization	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1238	Molecular	"Lipid membranes, proteins, DNA"	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1238	Molecular	"Lipid membranes, proteins, DNA"	increased process quality
Aop:196	Adverse outcome pathway for airway irritation and chemical sensitization	Event:1238	Molecular	"Lipid membranes, proteins, DNA"	increased process quality
Aop:197	Sodium channel (Nav1.1) inhibition leading to population decline	Event:584	Molecular	Inhibition	decreased process quality
Aop:197	Sodium channel (Nav1.1) inhibition leading to population decline	Event:1176	Cellular	Decreased	decreased process quality
Aop:197	Sodium channel (Nav1.1) inhibition leading to population decline	Event:1179	Cellular	Decreased	decreased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1181	Molecular	Activation	increased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1182	Cellular	Increase	increased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1183	Cellular	Decreased	decreased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:177	Cellular	N/A	damage
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1088	Cellular	Increased	increased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1187	Molecular	Increased	increased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1188	Molecular	Increased	increased process quality PATO:0002304
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1189	Cellular	Increased	increased process quality PATO:0002304
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1190	Cellular	Increased	increased process quality PATO:0002304
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1191	Cellular	Increased	
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1192	Tissue	Increased	increased process quality PATO:0002304
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1193	Individual	N/A	pathological
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1194	Molecular	Increased	damage
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1195	Cellular	modulation	deformed
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1196	Cellular	Increased	
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1197	Cellular	Activation	decreased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1198	Cellular	Activation	decreased process quality
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1213	Cellular	Increased	increased process quality PATO:0002304
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1239	Molecular	Altered	deviation(from_normal)
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1240	Cellular	Altered	deviation(from_normal)
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1241	Cellular	"Increased, Motility"	
Aop:200	Estrogen receptor activation leading to breast cancer	Event:1242	Cellular	Increased	increased process quality PATO:0002304
Aop:201	Juvenile hormone receptor agonism leading to male offspring induction associated population decline	Event:1205	Molecular	Activation	increased process quality PATO:0002304
Aop:201	Juvenile hormone receptor agonism leading to male offspring induction associated population decline	Event:1206	Molecular	Induction	
Aop:201	Juvenile hormone receptor agonism leading to male offspring induction associated population decline	Event:1208	Population	Increased	increased object quality
Aop:201	Juvenile hormone receptor agonism leading to male offspring induction associated population decline	Event:1208	Population	Increased	increased object quality
Aop:201	Juvenile hormone receptor agonism leading to male offspring induction associated population decline	Event:1209	Organ	Induction	increased object quality
Aop:201	Juvenile hormone receptor agonism leading to male offspring induction associated population decline	Event:361	Population	Decline	decreased rate
Aop:201	Juvenile hormone receptor agonism leading to male offspring induction associated population decline	Event:1210	Population	Alteration	deviation(from_normal)
Aop:206	Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis	Event: 1270	Molecular		increased process quality PATO:0002304
Aop:206	Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis	Event: 1271	Molecular		increased process quality PATO:0002304
Aop:206	Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis	Event: 1272	Cellular		increased process quality PATO:0002304
Aop:206	Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis	Event: 1274	Cellular		increased process quality PATO:0002304
Aop:206	Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis	Event: 1273	Cellular		increased process quality PATO:0002304
Aop:206	Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis	Event: 1275	Tissue		increased object quality
Aop:206	Peroxisome proliferator-activated receptors ?? inactivation leading to lung fibrosis	Event: 1276	Organ		occurrence
Aop:207		Event:1174	Molecular	"Activation,"	increased process quality PATO:0002304
Aop:207		Event:1278	Molecular		increased process quality PATO:0002304
Aop:207		Event:1279	Cellular	Increase	increased object quality
Aop:207		Event:1279	Cellular	Increase	increased process quality PATO:0002304
Aop:207		Event:1280	Cellular	"Activation,"	increased process quality PATO:0002304
Aop:207		Event:1281	Cellular	Increased	increased process quality PATO:0002304
Aop:207		Event:176	Cellular	Damaging	damage
Aop:207		Event:1262	Tissue		increased process quality PATO:0002304
Aop:207		Event:1277	Individual		decreased process quality
